Full-Time

Senior Vice President Business Development

Posted on 9/11/2026

Deadline 9/11/27
IBEX

IBEX

1-10 employees

Biotech company: antibodies and gene therapy

No salary listed

Washington, DC, USA

In Person

Bachelor's, MBA

Category
Sales & Account Management (1)
Required Skills
Sales
Lead Generation

Get referred to IBEX

See people who can refer or advise you

Requirements
  • Bachelor’s degree in Business, Marketing, or a related field.
  • 10+ years of progressive experience in business development, sales, or client acquisition within the BPO, CX, or outsourcing industry.
  • Proven track record of closing large, complex, multi-year deals with enterprise clients.
  • Demonstrated success selling into the BFSI, banking, and fintech verticals.
  • Deep understanding of industry-specific challenges, compliance requirements, and customer experience expectations within BFSI and fintech.
  • Established network and relationships within one or more target verticals.
  • Strong understanding of global delivery models and outsourcing solutions.
  • Ability and willingness to travel as needed to support client engagement and deal closure.
Responsibilities
  • Develop and execute a strategic sales plan aligned with company growth objectives.
  • Identify, target, and secure new business opportunities across priority verticals, including BFSI and fintech.
  • Build and maintain a robust pipeline of qualified prospects and manage the full sales lifecycle from lead generation through close.
  • Establish and nurture C-level client relationships to drive long-term partnerships.
  • Collaborate with internal stakeholders, including Operations, Solutions, and Finance, to develop tailored, competitive proposals.
  • Lead RFP and RFI responses, client presentations, and contract negotiations.
  • Consistently meet or exceed revenue targets and sales quotas.
  • Stay informed on industry trends, market dynamics, and competitive positioning within target verticals.
  • Partner with marketing to align demand generation strategies with target industries.
  • Provide regular pipeline forecasts and sales reporting to executive leadership.
Desired Qualifications
  • MBA.
  • Banking-sector sales experience within the BFSI vertical.

Ibex Biosciences focuses on discovering, validating, and producing biotechnology solutions for health and ecological challenges. Its product portfolio includes therapeutic antibodies, gene therapy, and stem cell programs, as well as diagnostic antibodies for Immunohistochemistry (IHC) to improve biopsy accuracy. The company advances its products by conducting exploratory R&D on projects that may not yet be validated in public research, then develops and commercializes these technologies through licensing, partnerships, and direct sales to healthcare and research institutions. A key differentiator is Ibex’s diversified, internally driven pipeline and its mix of therapeutics and diagnostics, alongside active engagement in grant funding and patenting. The company’s goal is to bring proprietary biotech innovations to market to enhance patient outcomes and health-related research, addressing significant cancer-related and other health challenges.

Company Size

1-10

Company Stage

Early VC

Total Funding

$4.2M

Headquarters

Rockville, Maryland

Founded

2015

Get referred to IBEX

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • May 6, 2026 revenue hit $164.4 million, up 16.8% year over year.
  • Management raised FY2026 guidance again on May 6, 2026, signaling sustained demand.
  • May 13, 2026 authorized a $20 million buyback, reinforcing cash generation and confidence.

What critics are saying

  • Telecommunications revenue fell 23.1% in Q3 FY2026; legacy contracts are shrinking.
  • Largest client drove 10% of revenue in Q3 FY2026; one churn hurts margins immediately.
  • GenAI contact-center rivals and client insourcing threaten ibex’s BPO volumes by 2027.

What makes IBEX unique

  • IBEX Limited pairs human agents with Wave iX AI across 2026 deployments.
  • March 31, 2026 filings show 98%+ revenue retention and diversified vertical exposure.
  • Offshore delivery supplied 51% of revenue in Q2 FY2026, lowering labor costs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Company News

Ibex Innovations
Mar 12th, 2025
IBEX Completes £2m Fundraise for Osteoporosis

IBEX has successfully completed a £2 million funding round to advance its mission of using X-ray technology to diagnose osteoporosis early. The company aims to shift from reactive to proactive treatment of this silent disease. With partnerships established with X-ray and mammography OEMs in 2024, IBEX plans to deploy its technology in clinical settings by 2025, demonstrating cost savings for the NHS.

Globes
Feb 8th, 2022
Gauzy acquires Vision Systems

Israeli light control nanotech and smart glass company Gauzy has announced that it has acquired French company Vision Systems, which develops ADAS (Advanced Driver Assistance System) and shading solutions for the aeronautic, land transport, and marine industries.